Therefore, we began our investigation with a pan-cancer screening of RPA1 using TCGA data, which revealed a significant up-regulation of RPA1 in liver hepatocellular carcinoma (LIHC) compared to adjacent normal tissue controls (p<0.001) (Supplementary Figure 1). Here, RPA1 is linked to cancer.